THE OVARIAN CANCER IN 3 POINTS

Relatively infrequent, the ovarian cancer is the 4th largest gynecological cancers. Often it is discovered late because it develops slowly and without specific symptoms. It was then that may be of poor prognosis, hence the need for regular gynecological monitoring.

1.What are the symptoms of ovarian cancer?
2.Risk factors of ovarian cancer
3.The diagnosis and treatment

One ovary may be affected, or both. In 80% of cases, tumors of the ovary develop from cells on the surface of the ovary (epithelial cancers). In most other cancers, tumors are derived from germ cells (which develop from cells producing eggs).

THE OVARIAN CANCER

What are the symptoms of ovarian cancer?

Early diagnosis of ovarian cancer is difficult because symptoms are nonspecific. Thus it is often detected late, when it extends to adjacent organs (fallopian tubes, uterus) or to other tissues (stomach, liver, intestine). Continue reading “THE OVARIAN CANCER IN 3 POINTS”

HORMONE REPLACEMENT THERAPY CONTINUOUSLY DECREASES THE RISK OF UTERINE CANCER

A recent study, combined hormone replacement therapy for menopause, continuous take, does not increase the risk of uterine cancer. Instead, it would seem protective.

1.The advantages of hormone replacement therapy

At the time of menopause, hormone replacement therapy based on estrogen is prescribed to combat the risks of estrogen deficiency (both short term on the symptoms of menopause such as hot flashes , on the long term aging the skin , arteries, etc..). Estrogens promote the proliferation of endometrial cells, it is recommended to associate with a progestin, which compensates this effect. Thus, the risk of uterine cancer is not increased with the treatment, called “combined” combining estrogen and progesterone. There are two types: continuous or discontinuous engagement (14 days per cycle).

THE RISK OF UTERINE CANCER

A team of researchers studied the effects of continuous combined hormone therapy in postmenopausal women with a cancer of the endometrial (uterine lining) by compared to a control population. Women who received continuous treatment, compared to patients not following any treatment, have a risk of uterine cancer by 0.6. This risk is 0.4 compared to intermittent hormone therapy. Taking continuous hormone substitutive over several years does not increase the risk of endometrial cancer, rather it tends to decrease, showing that combined form (estrogen and progesterone) is continuous in the most advantageous. Continue reading “HORMONE REPLACEMENT THERAPY CONTINUOUSLY DECREASES THE RISK OF UTERINE CANCER”

BONE CANCER, EWING’S SARCOMA

Ewing sarcoma is a bone cancer. This cancer is serious, but the prognosis has been greatly improved thanks to treatment advances in chemotherapy and radiotherapy.

-Ewing’s sarcoma: a primary bone cancer
-Bone cancer: what are the symptoms of Ewing’s sarcoma?
-Ewing sarcoma: sometimes surgery, chemotherapy and radiotherapy but otherwise

EWING'S SARCOMA

Ewing’s sarcoma: a primary bone cancer

Ewing sarcoma is one of the primary tumors of bone, that is to say that cancer cells originate from bone, and that are not met static cancer located elsewhere in another organ. Ewing sarcoma is unique in touch more often men than women. It also develops mainly in children between 10 and 15 years , more rarely in young adults up to age 25. Cancer cells usually reach the long bones like the femur and tibia. Thus Ewing sarcoma most often for the arms and legs, even though this cancer can affect any bone. Continue reading “BONE CANCER, EWING’S SARCOMA”

YOU TAKE THE PILL? YOUR RISK OF OVARIAN CANCER IS DECREASED!

Fairly uncommon, ovarian cancer is daunting because of its poor prognosis. A new study confirms the protective role of oral contraception. The advantage is that even 30 years after stopping the pill, the protection lasts …

1.Against ovarian cancer, gynecologic surveillance is needed
2.One factor that protects against ovarian cancer: oral contraception

Against ovarian cancer, gynecologic surveillance is needed

YOUR RISK OF OVARIAN CANCER

The poor prognosis of ovarian cancer is related to the fact that it is very long asymptomatic and therefore detected late, a late stage. In this context, prevention is a considerable asset. It is recommended that a very regular gynecological monitoring and consult your doctor or gynecologist if signs suggestive (but not specific for ovarian cancer): swelling or tension of the abdomen, feeling of weight on his stomach, and pelvic pain lumbar, needs to urinate, digestive disorders, weight changes, menstrual irregularities, painful intercourse, fatigue, etc.. Continue reading “YOU TAKE THE PILL? YOUR RISK OF OVARIAN CANCER IS DECREASED!”

RED MARKS AND ROUGH ON THE SKIN: AND IF IT WAS CANCEROUS?

Actinic keratosis, you know? This skin condition is characterized by small red-brown lesions and rough, which have the particularity of not cure but to persist for months on the areas most exposed to the sun. However, actinic keratosis can lead to precancerous lesions.

1.Actinic keratosis, it looks like what?
2.What might we do with an actinic keratosis?
3.Who is at risk of actinic keratosis?
4.How to treat actinic keratosis?

RED-MARKS

Actinic keratosis, it looks like what?

Traces red or brown, rough, dry and more or less thick, which appear after middle age, especially in areas that were most exposed to the sun: the face (forehead, nose, eye), chest, back hands, forearms, neck, ears, scalp if hair loss, etc.. They sometimes look like patches of psoriasis or eczema, but they have the distinction of not heal, even after applying a cream containing cortisone. They persist for months. Continue reading “RED MARKS AND ROUGH ON THE SKIN: AND IF IT WAS CANCEROUS?”

WHAT IS A SECONDARY BONE CANCER? WHEN A CANCER CAUSING ANOTHER CANCER …

Bone cancers represent malignancies developing inside the bones. Are differentiated primary cancers of bone, developed from bone cells, secondary cancers of the bones are actually metastases of another cancer in another part of the body.

-Bone cancer may be the result of bone metastases of another cancer
-Secondary bone cancer bone pain and fractures
-The diagnosis of secondary bone cancer
-Treatments depend on the origin of cancer remote

ANOTHER CANCER

Bone cancer may be the result of bone metastases of another cancer

Secondary bone cancers are actually bone metastases from cancer of another organ, such as a prostate cancer, thyroid, breast, kidney, lung, etc.. In other words, they are localized cancer that eventually spread to invade the bone, destroying it little by little. Cancer can spread to any bone but they generally do not exceed the elbows and knees. This type of bone cancer, Su bone metastases is called a secondary bone cancer. Continue reading “WHAT IS A SECONDARY BONE CANCER? WHEN A CANCER CAUSING ANOTHER CANCER …”

WHAT IS YOUR RISK OF COLORECTAL CANCER?

Second cancer in women (after breast cancer) and third in men (after lung cancer and prostate cancer), colorectal cancer is very common. Since 2009, cervical cancer screening is widespread throughout France. The goal: to detect this cancer as soon as possible to increase the effectiveness of treatments. And you, what is your risk of colorectal cancer?

What is your age:
You are under 50 years. (0)
Over 50 years to 74 years. (1)
You are over 74 years. (0)
Colorectal cancer mainly affects people over 50 years. That is why the screening program recommends a test every two years, 50 to 74 years (being a cancer that develops slowly, it does not seem essential to continue screening beyond old age ).

COLORECTAL CANCER

Do you have a history of colon cancer in your family?
No. (0)
A person. (1)
Several people. (2)
Any family history of colorectal cancer increases the risk of suffering also. Continue reading “WHAT IS YOUR RISK OF COLORECTAL CANCER?”

COLORECTAL CANCER AND GENETIC PREDISPOSITION

The screening program for colorectal cancer is for all people aged over 50 years. Diagnosed early, it can be cured in more than 9 out of 10. However, there are cases of inheriting the cancer colorectal requiring special care including a consultation with a geneticist.

1.The high incidence of colorectal cancer
2.Aggravating factors and protective for colorectal cancer
3.Genetic predisposition for colorectal cancer
4.The colorectal cancer screening

COLORECTAL

When colorectal cancer is detected early, the chances of recovery above 90%. Mass screening using the Hem occult II ®, now organized throughout the country, to identify early colorectal cancer and thus significantly improve the prognosis of the patient. Operation “Blue March” aims to further sensitize the population on this screening too little follow-up since the national participation rate over the period 2009-2010 is 34% (1). Continue reading “COLORECTAL CANCER AND GENETIC PREDISPOSITION”

COLORECTAL CANCER: THE HEMOCCULT II TEST IN PRACTICE

No mercy for colorectal cancer. This is the third most common cancer and is often fatal. The only weapon we have right now is early detection. This is based on the Hem occult II, which is being extended as part of an organized screening.
1.Colorectal cancer screening: Hem occult II
2.When the test is positive: colonoscopy to look for colorectal cancer
3.Soon a new immunoassay to screen for colorectal cancer

Colorectal cancer screening: Hem occult II

This test is ordered by a physician (within the screening program or not). It occurs quietly at home. Its cost and playback are supported 100% by health insurance as part of organized screening. It is to investigate the presence of bleeding in the stool, which may reflect a colorectal cancer.

CANCER

The Hemoccult II consists of a guaiac test paper onto which is applied a small piece of freshly emitted saddle. It is then a medical analysis laboratory that will take the reading test by adding a solution alcoholic hydrogen peroxide. If the reaction does not give a blue color, is that the test is negative. And this is what happens in 97 to 98% of cases. A negative Hem occult test means that no bleeding was detected. However, since a cancerous lesion does not cause bleeding all the time, it is imperative to repeat this test regularly, every two years. Continue reading “COLORECTAL CANCER: THE HEMOCCULT II TEST IN PRACTICE”